5.JPG)
The Global Next Generation Sequencing Library Preparation Market Size is valued at USD 1.76 billion in 2023 and is predicted to reach USD 4.53 billion by the year 2031 at a 12.76% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increasing number of applications for next-generation sequencing technology and supplier collaboration to develop automated library preparation techniques bode well for the market's future growth.
- Promising innovations in next-generation sequencing (NGS) devices and technology are anticipated to fuel substantial industry expansion in the years ahead.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- There are competing technologies that might slow the growth of this industry, and the chances of discovering useful mutations for precision medicine are low.
The massively sequencing technology known as "next-generation sequencing" (NGS) provides extremely high throughput, scalability, and speed. The global market for NGS sample preparation is projected to be stimulated by developments in the life sciences sector that reduce workflow to increase effectiveness and quality. The main obstacles to the expansion of this industry include issues with regulations and standards in diagnostic testing, as well as the limited experience and sequencing capabilities of mid and small-sized laboratories. Companies in the NGS sample preparation market are expanding their income streams by taking advantage of new animal research and agriculture prospects. This is clear given that the market is expected to grow at an astounding CAGR throughout the evaluation period. The need for NGS sample preparation will continue to grow both now and in the future.
Furthermore, the current studies and research in this area fuel the market expansion for NGS sample preparation. Governmental and non-governmental entities fund research organizations for their NGS sample preparation initiatives. Businesses in the NGS sample preparation market are building a solid research foundation for determining how coronavirus strains may impact animal health. To prevent food waste globally, NGS is assisting in tracing the origin of plant illnesses. A thorough description of the RNA and DNA virome that causes foodborne viral infections is also provided by viral partial genomic sequencing.
Competitive Landscape
Some major key players in the Next Generation Sequencing Library Preparation market
- Agilent Technologies, Inc
- Integrated DNA Technologie
- Hoffmann-La Roche AG, Inc
- Illumina, Inc
- Becton, DickinCompany company
- Merck KGaA
- Dickinson and Company
- New England Biolabs, Inc
- PerkinElmer Inc
- QIAGEN N.V
- Pacific Biosciences of California, Inc
- Thermo Fisher Scientific Inc
- Tecan Group Ltd
- Other Prominent Players
Market Segmentation:
The next-generation sequencing library preparation market is segmented on the sequesncing type, product, applications and end-use. Based on the sequencing type, the next-generation sequencing library preparation market is segmented into Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, and Other Sequencing Types. Based on product, the next-generation sequencing library preparation market is segmented into Reagents & Consumables (DNA library preparation kits, library preparation kits, RNA library preparation kits, other reagents & consumables) and instruments. Based on application, the next-generation sequencing library preparation market is segmented into Drug & Biomarker Discovery, Disease Diagnostics (Cancer Diagnostics, Reproductive Health Diagnostics, Infectious Disease Diagnostics, Other Disease Diagnostic Applications), drug discovery and other applications. Based on end-use, the next-generation sequencing library preparation market is segmented into Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others.
Based on the product, the library preparation kit segment is a major contributor to the next-generation sequencing library preparation market.
The most significant revenue share was accounted for by the library preparation category, which is anticipated to dominate the NGS sample preparation market over the projected period because of the rising prevalence of cancer medical problems and the increased importance of research operations. Furthermore, new opportunities for sample sequencing at astounding levels of coverage have been opened up by recent developments in library preparation sequencing kits. With technology, library preparation can sequence nucleic acids and has significantly higher sensitivity than other traditional approaches.
The hospital & diagnostics segment witnessed growth at a rapid rate.
Hospitals & diagnostics grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the expected time. The high proportion of this market can be ascribed to some factors, including the expanding applications of NGS in medicine, the rising use of NGS in the diagnosis of infectious diseases, hereditary diseases, and cancers, and the expanding use of precision medicine. The accuracy and consistency of genetic diagnosis have increased due to the growing use of NGS in diagnostic laboratories. Advanced genetic diagnostic techniques are used in prenatal and predictive genetic testing.
The North American next-generation sequencing library preparation market holds a significant regional revenue share.
The North American next-generation sequencing library preparation market is expected to register the highest market share in revenue soon. This is because sequencing technology and NGS sample preparation sequencing solutions are widely used there. Additionally, the rise in NGS-based clinical and research applications and the favourable government and private body activities for developing and implementing NGS technologies all contribute to the regional market's growth. Besides, the Asia Pacific market is anticipated to grow the fastest over the next few years. The expansion of medical research, the growing popularity of specific treatments, and the presence of eminent service providers in the area are further likely to boost the regional market growth.
Recent Developments:
- In January 2024, Illumina Inc. announced a partnership with Janssen Research & Development, LLC (Janssen). This partnership marks the first of its kind for the creation of Illumina's innovative molecular residual disease (MRD) test, which is a multi-cancer research solution based on whole-genome sequencing (WGS) that can identify circulating tumor DNA (ctDNA) to elucidate the prolongation or return of disease after therapeutic intervention.
- In January 2024, Promega revealed a novel approach to treating hematological cancers, such as multiple myeloma, in a paper published in Nature Communications. The chemical SJ3149 has a substantial anti-proliferative effect in many human cancer cell lines by selectively breaking down the cancer-causing protein CK1α.
Global Next Generation Sequencing Library Preparation Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.76 billion |
|
Revenue Forecast In 2031 |
USD 4.53 billion |
|
Growth rate CAGR |
CAGR of 12.76% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Sequencing Type, Product, Application, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Agilent Technologies, Inc., Integrated DNA Technologies, F. Hoffmann-La Roche AG, Inc., Illumina, Inc., Beckman Coulter Inc. (now part of Danaher Corporation), Merck KGaA, Becton, Dickinson and Company, New England Biolabs, Inc., PerkinElmer Inc., QIAGEN N.V., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., and Tecan Group Ltd. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
